Irene E Legiec

Title: Irene E Legiec: Innovator in Pharmaceutical Chemistry

Introduction

Irene E Legiec is a notable inventor based in Mountainside, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the body.

Latest Patents

Irene holds a patent for her invention titled "(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists." This invention encompasses compounds of Formula I, along with their pharmaceutically acceptable salts. The compounds function as S1P/Edg1 receptor agonists, exhibiting immunosuppressive, anti-inflammatory, and hemostatic activities. These effects are achieved by modulating leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity. Additionally, the invention includes pharmaceutical compositions containing these compounds and methods for treatment or prevention.

Career Highlights

Irene is associated with Merck & Company, Inc., where she has been instrumental in advancing research and development in her area of expertise. Her work has contributed to the understanding and application of receptor agonists in therapeutic settings.

Collaborations

Irene has collaborated with esteemed colleagues, including Vincent Colandrea and George A Doherty, to further her research and innovations in the pharmaceutical field.

Conclusion

Irene E Legiec's contributions to pharmaceutical chemistry, particularly through her patented inventions, highlight her role as an influential inventor in the industry. Her work continues to impact the development of new therapeutic strategies.